|
Platelet radiolabeling procedure.
Transfusion. 2006 Nov; 46(Suppl 3):59S-66S.
The Biomedical Excellence for Safer Transfusion (BEST) Collaborative. |
|
Primary and secondary hemostatic functionalities of rehydrated, lyophilized platelets.
Transfusion. 2006 Nov; 46(11):1943-50.
Fischer TH, Bode AP, Parker BR, Russell KE, Bender DE, Ramer JK, Read MS. |
|
Disabled-2 is a novel {alpha}IIb-integrin-binding protein that negatively regulates platelet-fibrinogen interactions and platelet aggregation.
J Cell Sci. 2006 Nov; 119(Pt 21):4420-30.
Huang CL, Cheng JC, Stern A, Hsieh JT, Liao CH, Tseng CP. |
|
Factor VIII is a positive regulator of platelet function.
Platelets. 2006 Nov; 17(7):448-53.
Obergfell A, Sturm A, Speer CP, Walter U, Grossmann R. |
|
A historical perspective on platelet radiolabeling techniques.
Transfusion. 2006 Nov; 46(Suppl 3):53S-8S.
Taylor HL, Whitley P, Heaton A. |
|
Heparin-induced thrombocytopenia in the critical care setting: Diagnosis and management;
Crit Care Med. 2006 Oct; Epub ahead of print Oct
Napolitano LM, Warkentin TE, Almahameed A, Nasraway SA. |
|
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP.
N Engl J Med. 2006 Oct; 355(16):1672-81.
Bussel JB, Kuter DJ, George JN, McMillan R, Aledort LM, Conklin GT, Lichtin AE, Lyons RM, Nieva J, Wasser JS, Wiznitzer I, Kelly R, Chen CF, Nichol JL. |
|
Novel Platelet and Vascular Roles for Immunoreceptor Signaling.
Arterioscler Thromb Vasc Biol. 2006 Oct; Epub ahead of print Sep
Samaha FS, Kahn ML. |
|
Lack of association between the platelet glycoprotein Ia C807T gene polymorphism and coronary artery disease: A meta-analysis.
Int J Cardiol. 2006 Oct; Epub ahead of print Sep
Tsantes AE, Nikolopoulos GK, Bagos PG, Vaiopoulos G, Travlou A. |
|
Possible mechanisms of drug-induced aspirin and clopidogrel resistance.
J Thromb Thrombolysis. 2006 Oct; 22(2):139-50.
Schroeder WS, Ghobrial L, Gandhi PJ. |
|
The role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular events.
J Thromb Thrombolysis. 2006 Oct; 22(2):103-10.
Pamukcu B, Oflaz H, Oncul A, Umman B, Mercanoglu F, Ozcan M, Meric M, Nisanci Y. |
|
Aspirin and clopidogrel resistance: consideration and management.
J Interv Cardiol. 2006 Oct; 19(5):439-48.
Gurbel PA, Tantry US. |
|
Phosphotyrosine signaling in platelets: lessons for vascular thrombosis.
Curr Drug Targets. 2006 Oct; 7(10):1265-73.
Wee JL, Jackson DE. |
|
G-protein dependent platelet signaling--perspectives for therapy.
Curr Drug Targets. 2006 Oct; 7(10):1253-63.
Shankar H, Kahner B, Kunapuli SP. |
|
Evidence that pre-existent variability in platelet response to ADP accounts for "clopidogrel resistance"
J Thromb Haemost. 2006 Sep; Epub ahead of print Sep
Michelson AD, Linden MD, Furman MI, Li Y, Barnard MR, Fox ML, Lau WC, McLaughlin TJ, Frelinger AL. |
|
Thrombin-triggered platelet apoptosis.
J Thromb Haemost. 2006 Sep; Epub ahead of print Ago
Leytin V, Allen DJ, Mykhaylov S, Lyubimov E, Freedman J. |
|
Identification of ADRA2A polymorphisms related to shear-mediated platelet function.
Biochem Biophys Res Commun. 2006 Sep; 347(4):1001-5. Epub 2006 Jul 10
Yabe M, Matsubara Y, Takahashi S, Ishihara H, Shibano T, Miyaki K, Omae K, Watanabe G, Murata M, Ikeda Y. |
|
Platelet function and pharmacologic inhibition.
Vasc Endovascular Surg. 2006 Sep; 40(4):261-7.
Chaer RA, Graham JA, Mureebe L. |
|
Acute coronary artery stent thrombosis following rapid renewal of functional platelets: Implications for intensified antiplatelet therapy.
Thromb Haemost. 2006 Sep; 96(3):384-6. No abstract available Ago
Schulz C, Schomig A, Kastrati A. |
|
Blood platelets activate the classical pathway of human complement.
J Thromb Haemost. 2006 Sep; 4(9):2035-42.
Peerschke EI, Yin W, Grigg SE, Ghebrehiwet B. |
